CYP46A1 and Alzheimer disease: Interestingly, the correlation of tau pathology with 24-OH levels, specifically with modulation of the enzyme CYP46A1, has been investigated by injecting the adeno-associated virus-CYP46A1 vector into the hippocampus of THY-Tau22 mice; these animals are considered to be a model of AD-like tau pathology.